OBJECTIVES: SF-36 is one of the most popular and extensively used health outcome measures. A large amount of resources have been devoted to examine the psychometric properties of SF-36, such as scale reliability, validity and the use of exploratory factor analysis or principal component analysis to identify the two latent constructs. However, few studies have examined the factor structure of SF-36 using the right tool -confirmatory factor analysis. None of the available studies have examined the factorial validity of SF-36v2. The study here is to investigate the factorial structure (construct validity) of SF-36v2 in the US general population using confirmatory factor analysis through structural equation modelling (SEM). METHODS: A sample consisting of 3844 non-institutionalized adults was drawn from the National Health Measurement Survey in the US and interviewed over the telephone. SF-36v2 was administered along with other health outcome measures. The factorial structure of SF-36 developed in Keller's paper (1997) was adopted as a point of departure for the other models. The model's goodness of fit to the data was evaluated using a number of fit indices, including CFI, TLI, SRMR, RMSEA, S-Bx2 Statistic and the corrected CFI. All analyses were performed using Mplus 3. RESULTS: Keller's model provided an adequate fit to the data. However, other models that allowed for error terms of items to covary improved the model fit dramatically. The most interesting finding was that the model that contained only the measurement part performed best. That is, a hierarchic structure did not improve the model fit to the data regardless of the composition of higher order factors. CONCLU-SIONS: The results supported the 8 hypothetical factors structure as proposed by the SF-36 developers. However, there were some doubts regarding the higher hierarchic construct of SF-36v2. Consequently, the use of two summary scores should be taken with caution. OBJECTIVES: The aim of the study was to investigate whether there are common problems that occur when translating (and linguistically validating) PRO measures for use in Slavic countries. METHODS: Past translation projects were selected, which had involved the translation of different PRO measures into two or more Slavic languages. All of the projects employed a standard methodology: 2 forward translations, reconciliation, 2 back translations and back translation review. All of the projects also used linguistic validation interviews with either patients or lay people, depending on the target population, or a clinician review. The documentation of each project was thoroughly examined to identify what the key issues were when translating PRO measures into Slavic languages. RESULTS: Translation issues were mainly linguistic in nature and in most cases were highlighted during the back translation step. Issues included: the omission of articles and possessive pronouns when Slavic languages are back-translated into English; more literal translations are often required to convey figurative ideas in English; Slavic translations cannot always be as concise as the source English and this often leads to the translation being more explanatory in nature; when compared to English, Slavic languages do not have such a wide array of synonymous terms, especially when describing graded emotional states-where English terms do not have a direct [Slavic] equivalent, it is essential to explain the intended meaning of the item in question to ensure that the final translation does not deviate conceptually from the source text. CON-CLUSIONS: When translating and linguistically validating PRO measures for use in Slavic countries it is important to be aware of the commonality found between the languages in this language group and to ensure that care is taken to maintain the conceptual equivalence between the source text and the Slavic translation. OBJECTIVES: Demographic factors such as age, gender or cultural factors may influence the utility value of health states and interact with health domain impact on utility. The aim of this analysis is to identify factors influencing utility values of EQ-5D and to estimate the relationships between additional variables and utility. METHODS: Data from study valuating EQ-5D with A570 Abstracts
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CHALLENGES OF TRANSLATING AND LINGUISTICALLY VALIDATING PRO MEASURES INTO SLAVIC LANGUAGES
Merry R, Houchin C, Wild D Oxford Outcomes Ltd, Oxford, UK OBJECTIVES: The aim of the study was to investigate whether there are common problems that occur when translating (and linguistically validating) PRO measures for use in Slavic countries. METHODS: Past translation projects were selected, which had involved the translation of different PRO measures into two or more Slavic languages. All of the projects employed a standard methodology: 2 forward translations, reconciliation, 2 back translations and back translation review. All of the projects also used linguistic validation interviews with either patients or lay people, depending on the target population, or a clinician review. The documentation of each project was thoroughly examined to identify what the key issues were when translating PRO measures into Slavic languages. RESULTS: Translation issues were mainly linguistic in nature and in most cases were highlighted during the back translation step. Issues included: the omission of articles and possessive pronouns when Slavic languages are back-translated into English; more literal translations are often required to convey figurative ideas in English; Slavic translations cannot always be as concise as the source English and this often leads to the translation being more explanatory in nature; when compared to English, Slavic languages do not have such a wide array of synonymous terms, especially when describing graded emotional states-where English terms do not have a direct [Slavic] equivalent, it is essential to explain the intended meaning of the item in question to ensure that the final translation does not deviate conceptually from the source text. CON-CLUSIONS: When translating and linguistically validating PRO measures for use in Slavic countries it is important to be aware of the commonality found between the languages in this language group and to ensure that care is taken to maintain the conceptual equivalence between the source text and the Slavic translation.
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INFLUENCE OF DEMOGRAPHIC AND CULTURAL PREDICTORS ON EQ-5D VALUE SET IN THE POLISH POPULATION
Wrona W, Golicki D, Jakubczyk M, Niewada M, Orłowski K, Gaczkowska A, Zawodnik S Medical University of Warsaw, Warsaw, Poland OBJECTIVES: Demographic factors such as age, gender or cultural factors may influence the utility value of health states and interact with health domain impact on utility. The aim of this analysis is to identify factors influencing utility values of EQ-5D and to estimate the relationships between additional variables and utility. METHODS: Data from study valuating EQ-5D with time trade-off for Polish population were used to evaluate influence of demographic, social and cultural factors on EQ-5D utility value. Based on additional data concerning demographic and lifestyle factors collected, adjusted modeling was performed using GRETL and WinBugs software. Impact of this factors was analyzed by directly including variables in the model, as well as adjusting for variables corresponding interaction between the factors and health domain. RESULTS: Data from 230 interviews (5280 valuations) were analyzed. Preliminary random effects model was developed, with constant and N3 factor, all coefficients statistically significant, R 2 equal to 0.37 and value -0.647 for 33,333 health state. After adjusting base model for gender and smoking no influence on utility value was observed. Including the interaction terms between age (0-1 variable defined as above/below median of 38 years) and belief in life after death (defined as strong agreement) with health domains (level 3) proved to be statistically significant and improved model R 2 up to 0.40. Direct influence of belief in life after death on the utility value of health states was significant, R 2 equal to 0.38 and coefficient value 0.16. CONCLUSIONS: Demographic and cultural factors influence the utility value of health in Polish population. According to results based on preliminary data belief in life after death significantly reduces utility loss.
PMC39 WHAT DOES ACCEPTABILITY MEAN FOR PATIENTS AND HOW SHOULD IT BE MEASURED? QUALITATIVE STEPS FOR THE DEVELOPMENT OF A NEW MEASUREMENT INSTRUMENT IN PHARMACIES
Marant C 1 , Longin J 2 , Spizak C 1 , Patrick DL 3 , Saussier C 2 , Arnould B 1 ,Van Ganse E 4 1 Mapi Values France, Lyon, France, 2 MAPI, Lyon, France, 3 University of Washington, Seattle, WA, USA, 4 Neuroepidemiology and Pharmacoepidemiology unit, Bron, France OBJECTIVES: Patient-Reported Outcomes (PRO) are routinely used to measure disease severity, perceived treatment impact, or patient attitude toward treatment. However, adherence can only partially be explained by clinical and PRO variables alone. Our objective is to develop a generic Acceptability measure assessing how patients balance out between advantages and disadvantages of long-term treatments. It could be used in future adherence studies through pharmacies. METHODS: A literature review was conducted in biomedical databases using keywords related to acceptability, perceptions, motivations and barriers linked to treatment. From 434 abstracts reviewed, 29 articles containing relevant concepts were retained to form the initial conceptual model of Acceptability. Exploratory interviews were performed with 5 pharmacists and 18 patients. They were recorded, transcribed word-for-word and systematically analysed. Concepts captured were organised into a detailed model used as a basis for the development of the test-version of the Acceptability questionnaire. RESULTS: The initial model of Acceptability included 6 global concepts: treatment perception, disease perception, judgement, behaviour, individual characteristics and medical context. The pharmacist interviews confirmed this model. The patient interviews confirmed the influence of treatment attributes on their Acceptability, but invalidated the concept of a judgment. The model adopted for the conceptual content of the Acceptability questionnaire covers 23 attributes organised in three major domains: efficacy, safety and convenience. Patients will be asked to rate how the treatment suits them, for each of the attributes. CONCLUSIONS: Qualitative research on Acceptability confirms the relevance of the concept for patients, but it also shows that judging whether a drug is good or not is left to the expertise of the health care professional. Appropriate wording was critical during item generation to capture the information in a way that make sense for the patients. After the testing and revision of the questionnaire, it will be able to be included in adherence studies.
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STABILITY OF TREATMENT SATISFACTION WITH MEDICINES QUESTIONNAIRE (SATMED-Q) STRUCTURE IN DIFFERENT PATHOLOGY SAMPLES
Ruíz MÁ 1 , Rejas J 2 , Pardo A 1 , Soto J 2 1 Universidad Autónoma de Madrid, Madrid, Spain, 2 Pfizer Spain, Madrid, Spain OBJECTIVES: Treatment Satisfaction (SATMED-Q) is a generic PRO instrument measuring Treatment satisfaction with medicines in chronic health conditions. Several multisample analysis are carried out in order to assess the stability of the questionnaire structure across of different types of patients, and to discover possible differences in dimension correlations for different drug treated pathologies. METHODS: Four samples of patients with different known pathologies following regular medication treatment were gathered from specialized units, and primary attention centres: hypertensive, drug-refractory-epilepsy subjects, caregivers of patients with dementia of the Alzheimer type and a normative sample. Exploratory factor analyses on each separate sample were carried out to assess sample specific structures. Multi-sample confirmatory factor analysis was used to assess the degree of agreement between sample structures using the known theoretical structure. Congruence statistics were also used with exploratory structures. RESULTS: A total of 2777 patients were gathered: 1,025 hypertensive patients -47% women, 63 (Ϯ11.3) years old-, 768 epileptic patients -65% women, 41 (Ϯ13.4) years old-, 842 Alzheimer patients caregivers -63% women, 78 (Ϯ6,8) years old-, and the normative sample used to develop the SATMED-Q composed by 442 patients of different pathologies -50% women, 62 (Ϯ13.6) years old-. The theoretical 6-factor solution identified in the original instrument was attained in all sample specific exploratory analyses. The multi-sample confirmatory analysis matched the 6-dimensional solution but usual goodness of fit problems with large sample sizes were found. Sample specific confidence intervals for factor loadings and factor correlations were obtained. Congruence statistics were reasonable, but were not able to explain differences in the obliqueness of factors. Meaningful differences in dimension correlations between samples were found. CONCLUSIONS: The structure of the SATMED-Q questionnaire is shown to be stable across different type of treatments and patients, but the relations between dimensions vary depending on the pathology studied.
